XTAP
"XTAP" is a word mark owned by Crosslink Therapeutics Inc., filed at the USPTO on June 15, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since September 28, 2026
- Filed
- June 15, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99884968
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns XTAP
The owner and representative on file with the office.
Owner
Crosslink Therapeutics Inc.
Boston, United States
Representative
Alexandria P Stiteler
Hoffmann & Baron, LLP
What the mark covers
The products and services XTAP is filed for, grouped by Nice class.
Biological preparations for the treatment of immunological and oncological conditions and diseases; Therapeutic biological preparations for use in Immunology and immuno-oncology
What has happened so far
Steps recorded by the USPTO, newest first.
- Notification of non-final action e-mailed
- Non-final action e-mailed
- Non-final action written
- Assigned to examiner
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About XTAP
Who owns the trademark "XTAP"?
The USPTO trademark "XTAP" (application 99884968) is owned by Crosslink Therapeutics Inc.
What is the status of "XTAP"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull XTAP and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019ed402-9115-7323-a02a-2f37f5ad66a6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019ed402-9115-7323-a02a-2f37f5ad66a6",
"object": "trademark",
"mark_text": "XTAP",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "99884968",
"filing_date": "2026-06-15",
"nice_classes": [
5
],
"owners": [
{
"name": "Crosslink Therapeutics Inc.",
"entity_id": null
}
]
}